Exosomes are thought to be released by all cells in the body and to be involved in
intercellular communication. We tested whether neural exosomes can regulate the …

Glioblastoma multiforme (GBM) is a highly aggressive and heterogeneous form of primary
brain tumors, driven by a complex repertoire of oncogenic alterations, including the …

Introduction RNA-based cancer gene therapy shows potential in cancer treatment. However,
the safe and efficient transfer of therapeutic RNA to target cells has always been a …

Glioblastoma (GBM) is an aggressive type of cancer that originates in the cells called
astrocytes, which support the functioning of nerve cells. It can develop in either the brain or …

Molecular biomarkers in blood are needed to aid the early diagnosis and clinical
assessment of glioblastoma (GBM). Here, in order to identify biomarker candidates in …

Exosomes and other extracellular vesicles have been gaining interest during the last
decade due to their emerging role in biology and, disease pathogenesis and their biomarker …

Gliomas are the most common type of the malignant brain tumor, which arise from glial cells.
They make up about 40% of all primary brain tumors and around 70% of all primary …

Background This study aimed to examine multi‐dimensional MRI features' predictability on
survival outcome and associations with differentially expressed Genes (RNA Sequencing) in …

We have studied differentially regulated nuclear proteome of the clinical tissue specimens of
glioblastoma (GBM, WHO Grade IV) and lower grades of gliomas (Grade II and III) using …

Glioblastoma is a highly malignant cancer with no effective treatment. It is vital to elucidate
the mechanisms which drive glioblastoma in order to identify therapeutic targets. The …